These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3175437)

  • 1. [Drug surveillance and the safety of drugs: guidelines for legislative and total cultural action].
    Laporte JR
    Rev Med Univ Navarra; 1988; 32(1):31-3. PubMed ID: 3175437
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacologic surveillance and safety of drugs: reflexions for legislative and, especially, cultural action].
    Laporte JR
    Rev Med Univ Navarra; 1988; 32(1):31-3. PubMed ID: 3154929
    [No Abstract]   [Full Text] [Related]  

  • 3. [The 1990 drug law. Its implications for the clinical doctor].
    Castillo Pérez P; Gutiérrez López JF
    Med Clin (Barc); 1992 Feb; 98(7):263-9. PubMed ID: 1560703
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharmacovigilance: theoretical and practical aspects].
    Paoletti V; Galeotta G; Mammarella A
    Clin Ter; 1997 Mar; 148(3):67-73. PubMed ID: 9377842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current status of the drug safety monitoring system in Korea.
    Park BJ
    Pharmacoepidemiol Drug Saf; 2001; 10(6):557-60. PubMed ID: 11828840
    [No Abstract]   [Full Text] [Related]  

  • 6. [The importance of health protection of the consumer in relation to veterinary drugs].
    Peters PW; Verburg H
    Tijdschr Diergeneeskd; 1987 Apr; 112(8):486-90. PubMed ID: 3576585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacovigilance: a case of phantom ships and Russian roulette].
    Stricker BH
    Ned Tijdschr Geneeskd; 2002 Jul; 146(27):1258-61. PubMed ID: 12138668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mandatory report of adverse effects of drugs: has the order modified the spontaneous notification?].
    Haramburu F; Pere JC; Begaud B; Albin H
    Therapie; 1988; 43(6):493-6. PubMed ID: 3227516
    [No Abstract]   [Full Text] [Related]  

  • 9. FDA attempting to overcome major roadblocks in monitoring drug safety.
    Zielinski SL
    J Natl Cancer Inst; 2005 Jun; 97(12):872-3. PubMed ID: 15956645
    [No Abstract]   [Full Text] [Related]  

  • 10. Generic Pharmaceutical Industry Association Orphan Drug Institute.
    Haddad W
    Prog Clin Biol Res; 1985; 197():41-5. PubMed ID: 4070298
    [No Abstract]   [Full Text] [Related]  

  • 11. Generic substitution: the use of medicinal products containing different salts and implications for safety and efficacy.
    Verbeeck RK; Kanfer I; Walker RB
    Eur J Pharm Sci; 2006 May; 28(1-2):1-6. PubMed ID: 16413762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beware of new drugs, study suggests.
    Levenson D
    Rep Med Guidel Outcomes Res; 2002 May; 13(10):1-2, 5. PubMed ID: 12492085
    [No Abstract]   [Full Text] [Related]  

  • 13. [The new norms decreed by the legislative dirrective 91-93 CCE].
    Neri M; Palazzo S
    Boll Chim Farm; 1998 Feb; 137(2):31-4. PubMed ID: 9595832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulating the fate of pharmaceutical drugs: a new prescription for the environment.
    Nidel CT
    Food Drug Law J; 2003; 58(1):81-101. PubMed ID: 12739585
    [No Abstract]   [Full Text] [Related]  

  • 15. Unlabeled drug samples and the learned intermediary: the case for drug company liability without preemption.
    Poser S
    Food Drug Law J; 2007; 62(4):653-94. PubMed ID: 18557225
    [No Abstract]   [Full Text] [Related]  

  • 16. [Registration of animal drugs].
    Abrahams CG; Bax CD
    Tijdschr Diergeneeskd; 1991 Apr; 116(7):371-3. PubMed ID: 2031243
    [No Abstract]   [Full Text] [Related]  

  • 17. The regulatory view on drug-drug interactions.
    Müller HJ; Gundert-Remy U
    Int J Clin Pharmacol Ther; 1994 Jun; 32(6):269-73. PubMed ID: 7921523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmaceutical postmarket review: fact or fiction?
    Schanz SJ
    Food Drug Law J; 2007; 62(3):493-500. PubMed ID: 17915391
    [No Abstract]   [Full Text] [Related]  

  • 19. "Black box" 101: How the Food and Drug Administration evaluates, communicates, and manages drug benefit/risk.
    Murphy S; Roberts R
    J Allergy Clin Immunol; 2006 Jan; 117(1):34-9. PubMed ID: 16387581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New regulations to speed drug approvals, improve safety monitoring.
    FDA Drug Bull; 1985 Apr; 15(1):2-3. PubMed ID: 3996801
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.